Research and Markets: Global Strategic Business Report on Anti-Obesity Drugs with Most Recent Key Developments and Future Products in the Pipleline

2005 through 2015. The report profiles 85 companies including many key and niche players worldwide such as * Abbott Laboratories (US) * Alizyme Plc (UK) * Amylin Pharmaceuticals, Inc. (US) * AstraZeneca Plc (UK) * F. HOFFMANN-LA ROCHE LTD....